Sina Bavari

This inventor holds 28 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Antiviral Compounds. Top assignees: US Government as Represented by the Secretary of the Army, Alnylam Pharmaceuticals, Inc., Avi Biopharma, Inc.. Active years: 2002-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sina Bavari. Retrieved from https://idiyas.com/inventor/sina-bavari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 11)

% Patents Active = 42.9

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 3.8

ph-index = 10

Forward Citations = 321(Granted Patents)

Location History:

Dillsburg, PA (US) (2002 - 2014)
Frederick, MD (US) (2003 - 2016)

Company Filing History:

20 out of 8,748

US Government as Represented by the Secretary of the Army

patents

7 out of 466

Alnylam Pharmaceuticals, Inc.

U.S. Army Medical Research and Material Command

patents

5. 1 out of 1

The United States of America as Represented by the Army Medical Research and Material Command

patent

6. 1 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 2002-2016

Loading Chart...

Areas of Expertise:

Fusion Protein

Filovirus Glycoprotein

Antisense Antiviral Compounds

Botulinum Neurotoxin

Bacterial Superantigen Vaccines

Gene Expression Inhibition

Ebola Virus

Small Molecule Inhibitors

Virus-Like Particles

Broad Spectrum Antibacterial

Antibodies

Pharmacophore Model

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9347951 - Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region (2016-05-24),

2. 9187516 - Compositions and methods for inhibiting expression of a gene from the Ebola virus (2015-11-17),

3. 8936915 - Cleavage sensitive antibodies and methods of use thereof (2015-01-20),

4. 8912316 - Compositions and methods for inhibiting expression of CD45 gene (2014-12-16),

5. 8735369 - Compositions and methods for inhibiting expression of a gene from the Ebola virus (2014-05-27),

6. 8710185 - Bacterial superantigen vaccines (2014-04-29),

7. 8691859 - Broad spectrum antibacterial compounds (2014-04-08),

8. 8354390 - Compositions and methods for inhibiting expression of a gene from the ebola virus (2013-01-15),

9. 8288525 - Compositions and methods for inhibiting expression of CD45 gene (2012-10-16),

10. 8168604 - Antisense antiviral compounds and methods for treating a filovirus infection (2012-05-01),

11. 8067202 - Bacterial superantigen vaccines (2011-11-29),

12. 8030292 - Antisense antiviral compounds and methods for treating a filovirus infection (2011-10-04),

13. 8030291 - Antisense antiviral compounds and methods for treating a filovirus infection (2011-10-04),

14. 7999001 - Antiviral compounds and methods of using thereof (2011-08-16),

15. 7973020 - Compositions and methods for inhibiting expression of a gene from the ebola virus (2011-07-05),

Title: The Innovative Journey of Inventor Sina Bavari

Introduction: Sina Bavari, a talented inventor based in Frederick, MD (US), has made significant contributions to the field of innovations with his creative mindset and dedication to problem-solving.

Latest Patents: Sina Bavari holds several patents in various technological areas, including advancements in renewable energy systems, smart home devices, and medical technologies.

Career Highlights: With a background in engineering and a passion for creating solutions that improve people's lives, Sina Bavari has successfully brought several groundbreaking inventions to the market. His commitment to innovation has led to the development of cutting-edge products that have garnered international recognition.

Collaborations: Throughout his career, Sina Bavari has collaborated with leading research institutions, universities, and companies to further enhance his inventions. His ability to work in multidisciplinary teams has resulted in the successful implementation of his ideas into real-world applications.

Conclusion: Sina Bavari's innovative spirit and relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on the world of technology serves as a testament to the power of creativity and perseverance in driving meaningful change.

Profile summary based on public USPTO records.